Intravenous immune globulin (IVIG) is a product prepared from human plasma used to treat a variety of immunodeficiency and autoimmune conditions.
Market trend Snapshot
Global Intravenous Immunoglobulin market was valued at 9,711 million USD in 2019 and estimated to reach 16,535 million USD by 2026, growing at a CAGR of 7.9%. This report provides comprehensive and in-depth analysis and prediction of the Intravenous Immunoglobulin industry.
First of all, the significant rise in geriatric population & number of hemophilic patients, improved technologies pertaining to the immunoglobulin production, and enhanced purification techniques are the major factors that propelling the Intravenous Immunoglobulin market. Secondly, the surge in prevalence diseases such as chronic inflammatory demyelinating polyneuropathy (CIDP), hypogammaglobulinemia, and others is expected to boost market growth. Apart from this, the high adoption of intravenous immunoglobulins for the treatment of various diseases is expected to create lucrative opportunities over the forecast period. On the contrary side, stringent government regulations toward the use of intravenous immunoglobulin products and high risk of side effects associated with them are expected to hinder the market growth.
From Base year 2018 to forecast year 2026
Get FREE Sample of Intravenous Immunoglobulin Market Report at:
Key Market Players Profile
Various market pacemakers covered in the report are Baxter, CSL, Grifols, Octapharma, Biotest, China National Pharmaceutical Group Corporation, China Biologic Products, Hualan Bio, RAAS, Shanxi Kangbao Biological Product, Kedrion Biopharma Inc., LFB group, BDI Pharma Inc., and Bayer Healthcare. The report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies, which will help companies create strategies to take advantages of the emerging opportunities in the future. Production and consumption are estimated to continue developing with a stable growth rate during the forecast period. As a result of meeting the surging demand, more manufacturers are expected to go into this industry.
North America holds the largest Intravenous Immunoglobulin market share
The report covers the major countries analysis in North America, Europe, Asia Pacific, and the rest of the world. Furthermore, policy mobilization, social dynamics, development trends, and economic development in these countries are also taken into consideration.
North America was the leading market with a share of 32.26% in 2018 and expected to grow at a stable rate during the predicted years. This is primely attributed to the increasing level of awareness pertaining to products involved in the treatment of immunodeficiency diseases, advanced medical technologies, rising inclination of clinicians towards these therapies and growing healthcare expenditure. Europe occupied a share of 31.95%, followed by the Asia Pacific with a share of 29.72%. The Asia Pacific is anticipated grow significantly during the forecast period owing to the increasing adoption of immunoglobulin-based therapies for the treatment of primary immune deficiencies, higher healthcare expenditure, growing geriatric population, and improvement of medical technology.
Intravenous Immunoglobulin Type and Application Sketch
By type
By application
Hypogammaglobulinemia segment occupied the largest market share in 2018 and is anticipated to continue this trend in the near future. This is mainly attributed to the significant rise in the prevalence of hypogammaglobulinemia disorder across the globe over the years. Furthermore, large patient population, lack of effective substitute treatment, and early adoption of immunoglobulin for the treatment of hypogammaglobulinemia are also expected to boost the growth of this segment.
Get FREE Sample of Intravenous Immunoglobulin Market Report at:
Intravenous Immunoglobulin Report provides
Table of Content
1 Report Overview
1.1 Product Definition and Scope
1.2 PEST (Political, Economic, Social and Technological) Analysis of Intravenous Immunoglobulin Market
…
2 Market Trends and Competitive Landscape
3 Segmentation of Intravenous Immunoglobulin Market by Types
4 Segmentation of Intravenous Immunoglobulin Market by End-Users
5 Market Analysis by Major Regions
6 Product Commodity of Intravenous Immunoglobulin Market in Major Countries
7 North America Intravenous Immunoglobulin Landscape Analysis
8 Europe Intravenous Immunoglobulin Landscape Analysis
9 Asia Pacific Intravenous Immunoglobulin Landscape Analysis
10 Latin America, Middle East & Africa Intravenous Immunoglobulin Landscape Analysis
11 Major Players Profile
11.1 Baxter
11.1.1 Baxter Company Profile and Recent Development
11.1.2 Market Performance
11.1.3 Product and Service Introduction
11.2 CSL
11.3 Grifols
11.4 Octapharma
11.5 Biotest
11.6 China National Pharmaceutical Group Corporation
11.7 China Biologic Products
11.8 Hualan Bio
11.9 RAAS
11.10 Shanxi Kangbao Biological Product
11.11 Kedrion Biopharma Inc.
11.12 LFB group
11.13 BDI Pharma Inc.
11.14 Bayer Healthcare.
…
Target Audience:
Get FREE Sample of Intravenous Immunoglobulin Market Report at:
Contact
Global Market Monitor
One Pierrepont Plaza, 300 Cadman Plaza W, Brooklyn,
NY 11201, USA
Name: Rebecca Hall
Phone: + 1 (347) 467 7721
Email: info@globalmarketmonitor.com
Web Site: https://www.globalmarketmonitor.com
We provide more professional and intelligent market reports to complement your business decisions.
Chinese